PrintShare


Press Releases

For Immediate Release
Contact: Melinda M. Bascone
Director of Marketing
Carter Ledyard & Milburn LLP
212-238-8753
info@clm.com

CARTER, LEDYARD & MILBURN ASSISTS DAKOCYTOMATION IN ACQUISITION OF LEADING CANCER DIAGNOSTIC INSTRUMENT FROM CYTOLOGIX

NEW YORK, September 5, 2002 - Wall Street law firm Carter, Ledyard & Milburn announced today that it represented DakoCytomation A/S in its acquisition of the Artisan® instrument business from CytoLogix Inc. CytoLogix' Artisan® is a state of the art tissue staining instrument used in pathology labs for cancer diagnosis. According to terms of the agreement, DakoCytomation will assume all rights to the product as well as responsibility for continued technical support and customer service.

DakoCytomation A/S is headquartered in Copenhagen, Denmark, and has significant R&D and manufacturing activities in the USA and in England. It is a leading in vitro diagnostic company specializing in the identification of cancer markers on samples obtained from tissue and body fluids. DakoCytomation's cutting-edge technology in immuno-chemistry, protein chemistry and instrument development enables physicians around the world to link diagnostic tests with specific therapies, thus optimizing patient treatment. The privately held company with operations in 20 countries and distributors in 50 other countries employs 1400 people. www.dakocytomation.com

CytoLogix Corporation, headquartered in Cambridge, Mass., is a leading innovator in laboratory technology for histology, molecular diagnostics and genomics. Its Artisan(R) instrument and reagent system automates complex staining processes for pathology laboratories. The Artisan instrument is the first slide-staining instrument to use individual slide heating, a technology that facilitates superior staining quality. www.cytologix.com

Carter, Ledyard & Milburn partner Alan J. Bernstein and associates Richard T. Califano, Peter Flägel, and Jeremy B. Hirsch assisted DakoCytomation with the transaction.

Carter Ledyard & Milburn LLP (www.clm.com), established in 1854, has approximately 90 attorneys and has been headquartered on Wall Street since its founding. Carter Ledyard's general practice includes corporate, securities, mergers and acquisitions, broker-dealer, on-shore and off-shore hedge and other alternative investment funds, private equity, litigation, intellectual property, environmental, employment, media and technology, immigration, investment regulation, antitrust, art law, trusts and estates, maritime, ERISA, tax-exempt organizations, real estate, tax and bankruptcy. A significant part of the firm's practice involves representing overseas-based clients and their U.S. affiliates, financial institutions and other financial services providers, governmental entities and media and technology clients.

Latest News

See all news items


© Copyright 2018 Carter Ledyard & Milburn LLP